Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01667172
Other study ID # S54271
Secondary ID
Status Completed
Phase N/A
First received August 14, 2012
Last updated August 15, 2012
Start date April 2012
Est. completion date June 2012

Study information

Verified date August 2012
Source Katholieke Universiteit Leuven
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

Study to test technical accuracy and userfriendliness of two Point-of-care C Reactive Protein devices (POC CRP devices) in comparison with laboratory CRP testing on children and adults.

Research questions:

1. Are the POC CRP devices technically accurate? Do the measured values agree with CRP values measured at the clinical laboratory?

2. Are the 2 POC CRP devices equivalent ? 2.1. Are the 2 POC CRP devices equally reliable? 2.1.1. Comparison of 2 measurements in the same patient on 1 device (inter-observer-variability) 2.1.2. Comparison of 2 measurements in the same patient on 2 identical devices (inter-device-variability) 2.2. Are the 2 Point-of-Care CRP devices equally userfriendly in a general practice surgery? (userfriendliness


Recruitment information / eligibility

Status Completed
Enrollment 300
Est. completion date June 2012
Est. primary completion date June 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 1 Month to 65 Years
Eligibility Inclusion Criteria:

- children: aged 1 month to 14 years

- adults: aged 18-65 years

Exclusion Criteria:

- children and adults not understanding Dutch language

Study Design

Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Diagnostic


Related Conditions & MeSH terms

  • Healthy and Acutely Ill Children & Adults

Intervention

Device:
Point-of-Care C Reactive Protein measurement on capillary blood
capillary blood fingerstick method to determine C Reactive Protein level in the blood

Locations

Country Name City State
Belgium Huisartspraktijken Leuven Vlaams-Brabant
Belgium Medisch Centrum voor Huisartsen Leuven Vlaams-Brabant
Belgium UZ Leuven Leuven Vlaams-Brabant

Sponsors (1)

Lead Sponsor Collaborator
Katholieke Universiteit Leuven

Country where clinical trial is conducted

Belgium, 

References & Publications (2)

Van den Bruel A, Haj-Hassan T, Thompson M, Buntinx F, Mant D; European Research Network on Recognising Serious Infection investigators. Diagnostic value of clinical features at presentation to identify serious infection in children in developed countries: a systematic review. Lancet. 2010 Mar 6;375(9717):834-45. doi: 10.1016/S0140-6736(09)62000-6. Epub 2010 Feb 2. Review. — View Citation

Van den Bruel A, Thompson MJ, Haj-Hassan T, Stevens R, Moll H, Lakhanpaul M, Mant D. Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review. BMJ. 2011 Jun 8;342:d3082. doi: 10.1136/bmj.d3082. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary technical accuracy correlation obtained between the results from the Point-of-care C Reactive Protein devices and the results from the laboratory 3 months No
Secondary User-friendliness evaluation of the userfriendliness by General Practitioners at 5 practices, on a five point Likert-scale scoring these criteria: device start-up, test duration, sample size, test characteristics, calibration, measuring range, handling of test tubes, filling of the capillary, placing the test cartridge, test recording and additional material usage. The median results are compared between both devices qualitatively. 3 months No
Secondary Inter-device variability The inter-device-variability (by 1 physician) was tested on 10 patients in one General Practice surgery each on two different Point-of-Care devices of the same brand. 3 months No
Secondary Inter-observer variability The inter-observer variability (by two physicians) was tested on 10 patients in one GP surgery on two different Point-of-care devices of the same brand. 3 months No